Site Search

... for the American Cancer Society Cancer Action Network (ACS CAN) in Connecticut: “Biomarker testing is essential to high-quality, personalized care for many conditions and can be a real gamechanger for many patients, but unfortunately, not everyone who can benefit from biomarker testing is getting it. There are significant disparities in health outcomes for Connecticut patients by race, income, and insurance type. Without addressing barriers to care, breakthroughs in personalized treatments could increase these disparities in health outcomes. “Expanding access to biomarker testing will help more people in Connecticut get the right treatment at the right time and avoid ...

NEW YORK, NY – November 16, 2023 – Earlier today, cancer survivors gathered in Times Square alongside health care providers and patient advocates to emphasize the importance of biomarker testing for the health of New York State, its people and its potential for an equitable, hope-filled future. Attendees of the rally called on Governor Hochul to ...

... disease.   Revolutionizing cancer treatment over the last few decades, biomarker testing can provide access to targeted treatment; tailoring care to a person’s individual disease. Targeted therapies often result in improved quality of life and survivorship. Patients with certain lung ... Network (ACS CAN).  “The General Assembly recognizes the importance of those scientific advancements and that true progress in Georgians’ health lies in ensuring more people across our great state have access to such innovations,”  Despite its benefits and increasingly important ... biomarker testing has not kept pace with the rate of innovation and advancements in treatment. One significant barrier for patients is lack of health insurance coverage for appropriate testing.  Close to 60% of the oncology drugs launched in the past five years require or recommend ...

... teamed up to sponsor this important next step in ensuring cancer patients have access to precision medicine. The UC system is a leader in cancer care through the UC Cancer Consortium which comprises five of the nation's 51 National Cancer Institute-designated Comprehensive Cancer Centers. ... cancer diagnosis across the state on an equitable basis,” said Carrie L. Byington, M.D., executive vice president of University of California Health. “California has the opportunity to be among the leaders in the nation with this legislation.” Despite its benefits, access to biomarker ... due to several factors, including low awareness of new testing methodologies among providers and patients and lack of coverage by private health insurance and Medicaid programs. “Biomarker testing and precision medicine have led to improved patient survival and quality of life,” ...